The global chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research, Inc. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach, such as the reduction in the overall R&D expenditure during the drug development process.
The ever increasing growth of the drug development market will boost the demand for chemoinformatics owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.
The significant contributions of the varying in silico tools in the generation of hits through the High Throughput Screening(HTS) process, target compound selection, virtual structure generation, Pharmacokinetic property and toxicity prediction of chemical compounds, and the quantitative-structure relationship determination have been a major driving force for the growth of the chemoinformatics market.
The heavy costs incurred along with the long time span invested in the drug discovery process has made the integration of the chemoinformatics techniques essential in the research activities. It aids the scientists and chemical researchers in making better decisions pertaining to drug discovery and other related research studies. Furthermore, the increasing demand for efficient and effective medicines, rising investments in R&D, growing geriatric population, and the burgeoning number of individuals with lifestyle related diseases are expected to positively reinforce the market growth. The key applications of the chemoinformatics tools and softwares in drug designing and discovery has been its largest application and is expected to grow further with further advances in the drug discovery process.
Chemoinformatics has made marked contributions to the areas of chemical drug development and research. The growth of this field is driven by the continually generated raw data in screening operations and research studies. Chemoinformatics in silico tools aid in effective data management, which facilitate data retrieval and analysis thus providing large databases of accessible information to scientists involved in both, the drug development process and other research related studies.
The development of three dimensional chemical structure databases has been a significant achievement in the field of chemoinformatics as it has significantly aided the research process. Applications of chemoinformatics platforms in computer-assisted synthesis designing, computer-assisted structure elucidation, and chemometrics have further contributed to the market growth.
The advancements in computational technology have been a high impact rendering driver for the market growth. In this direction, the development of super computers and silicon graphics computer for calculations, 3D structure generation, molecular graphics, and complex data display have been pivotal in propelling the growth of the chemoinformatics market. With the advent of advanced WEB technologies and their incorporation in the in-silico computational techniques have totally revolutionized this field.
The increasing needs for advanced and efficient technologies to yield better results has made the chemoinformatics area an indispensable part of the pharmaceutical industry. The surging need for therapeutically-effective medicines coupled with the increasing investments in the R&D area and the advancements in computer technologies provide lucrative opportunities to the market for it to grow and flourish in the near future.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market
Further key findings from the study suggest:
·
In 2015, North America dominated the
chemoinformatics market with a revenue share of over 36% on account of the
following factors: the high investments pertaining to the R&D
initiatives, technological advancements, the presence of major players in the
drug manufacturing industry, and the increasing prevalence of lifestyle-related
diseases. With respect to the global R&D spending, North America holds the
largest share. Also, it holds a major share in the ADME-toxicology market that
further spurs the growth of the chemoinformatics market.
·
Asia Pacific is identified as one of the fastest
growing regional markets, growing at a lucrative CAGR of 18.3% during the
forecast period. The growth of this market can be attributed to the growing
research activities being conducted in economies, such as India, China, and
Singapore. The key advantages associated with undertaking research activities
in these countries include the low manufacturing and labor costs and the less
stringent regulations, which attract many multinational players to the Asia
Pacific region. Additionally, the government initiatives and funds that are
deployed to improve the R&D infrastructure will further drive the market
growth.
·
Key players operating in the market include
Agilent Technologies, Inc., BIOVIA (Accelrys), Bio-Rad Laboratories, Inc.,
CambridgeSoft Corp., ChemAxon, Inc., ACD/Labs, Inc., Schrödinger, LLC, and
Chemical Computing Group, Inc. Additionally, the rising demand for in-silico
techniques in the research sector is expected to provide new market
entrants with profitable opportunities thereby driving the market growth.
Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market/request
Grand View Research has segmented the chemoinformatics market by applications:
Global Chemoinformatics Market, by Application (USD Billion, 2016 - 2024)
·
Chemical Analysis
·
Drug Discovery
·
Drug Validation
·
Others
Chemoinformatics Market Regional Outlook, by Revenue (USD Billion,
2016 - 2024)
·
North America
·
U.S.
·
Canada
·
Europe
·
Germany
·
UK
·
Asia Pacific
·
Japan
·
China
·
India
·
Latin America
·
Brazil
·
Mexico
·
MEA
·
South Africa
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it
